Skip to main content Skip to footer

Innovation in life sciences

Delivering new strategies and assets to drive growth, embrace disruption and implement change for lasting impact powered by intelligent technology.

The industry is constantly being disrupted by invention, technology and patient expectations.

Drug discovery and development are transforming at an unprecedented pace. Soon technology will enable novel therapy design and delivery in a new era of efficiency, precision and groundbreaking medical advancements.

We must be ready to think, work and act differently. This is the purpose of innovation.

DATA

92%

of biopharma executives identify AI as critical, so the urgency to innovate in life sciences is paramount.

98%

of biopharma executives expect employee tasks to shift significantly toward innovation in the next three years.

54%

AI agents are expected to enhance innovation (54%), increase flexibility (41%), and improve development speed (41%) within MedTech organizations in the next 3 years.

How innovation in life sciences is changing

slideText 1 ofText 1

At the core of our industry

Invention is core to the life sciences industry. We are scientists and our world is ever-changing, driven by external disruption, tech advances and evolving patient needs. Generative AI is only the most recent disruption to reshape our industry. It provides exciting advancements that will allow us to think, act and work differently in the service of our patients.

Predictive and data-driven

Predictive innovation can be enabled by harnessing vast amounts of clinical, genomic, and patient data to identify trends, disease patterns and treatment needs. Researchers and biopharma organizations can now anticipate medical challenges, discover new drug targets, personalize therapies and develop solutions before diseases progress or new health threats arise.

Collaboration is key

Innovation thrives on collaboration. By integrating capabilities across evolving partner ecosystems, we reshape how organizations think, connect and create—unlocking new possibilities through shared vision and collective strength.

Tech-enabled, human-delivered

Innovation is realized when technology, ecosystem and human expertise are integrated with intent. By aligning capabilities, context and leadership vision, we move beyond pilots to scalable transformation—delivering meaningful change across industries and functions.

What you can do

Redesign workflows to accelerate your reinvention strategy. By integrating user-centric design, tech futures and bespoke tooling - including Gen AI/Agentic assets and accelerators - we deliver transformative, scalable innovation.

Learn more

Collaborate with global innovation hubs to co-create future visions and accelerate strategy implementation, leveraging shared expertise and resources to drive business growth and adaptability.

To maximize the impact of reinvention, we must focus on how people trust, interact with and adapt to new tools and workflows. Consciously foster a culture of learning and innovation. Bespoke innovative offerings accelerate the effectiveness of your transformation as you embed technological change.

Adopt agile processes within R&D and other departments to enable more responsive changes and drive iterative improvements. This can reduce development cycles and make product iterations more adaptable to market needs.

Learn more

Create seamless data flow across platforms to enhance decision-making and efficiency. Foster collaboration with adaptable, interconnected systems to outpace competitors.

Our leaders

Dr Órlaith Burke

Managing Director – Global Life Sciences Innovation Lead

LinkedIn

Tina Ripperger

Managing Director – Life Sciences Innovation, Americas Lead

LinkedIn